Multiparametric MR microimaging deteced differences in pancreatic microstructure between two mouse models of pancreatic cancer, EL-KRASG12D (EK) and p48-Cre/LSL-Kras (KC) mice, that overexpress mutant KRas via different mechanisms. MR signatures characteristic of acinar-ductal metaplasia, fibrosis, cystic neoplasms and precancerous lesions revealed different trajectories of disease development between the two genetically engineered mice.
This abstract and the presentation materials are available to members only; a login is required.